ABOUT AUTHORS:
DEVENDRA SINGH1*, PANKAJ KUMAR SHARMA1, ROOHI KESHARWANI2, Dr. UDAI VIR SINGH SARA1
1Raj kumar goel institute of technology, Delhi-Meerut Road, Ghaziabad, India
2Chandra shekhar singh college of pharmacy, Kaushambi, Uttar Pradesh, India.
* devendrasingh.pisces@gmail.com
ABSTRACT:
Oral administration still dominates drug therapy and more than 60 % of marketed drugs are oral products. This type of drug administration is preferred due to its convenience, high patient compliance, less stringent production conditions and lower costs. Unfortunately, this traditional drug delivery method has its limitations, due to gastrointestinal permeability, metabolism and elimination of drugs by the liver or gastrointestinal mucosa (first-pass effect). The main drawback of the oral route is that only those compounds that are stable in the gastrointestinal tract can be administered in this way. For this reason, the oral route has been used for mainly non-peptide drugs. Delivery of a drug by oral route is predominantly restricted by pre-systemic degradation and poor penetration across the gut wall. The major challenge in the oral drug delivery is the development of novel dosage forms to endorse absorption of poorly permeable drugs across the intestinal epithelium. In this article we reviewed the various permeation enhancers, histology of small intestine, barriers, application, advantages, some basic permeability enhancement techniques which are useful for enhancing the permeability of poorly permeable drugs
(adsbygoogle = window.adsbygoogle || []).push({});
About Author: 
.png)
